Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
266M
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
64.1M
-
Shares change
-
+5.78M
-
Total reported value, excl. options
-
$1.26B
-
Value change
-
+$105M
-
Number of buys
-
51
-
Number of sells
-
-27
-
Price
-
$19.66
Significant Holders of Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA) as of Q2 2021
94 filings reported holding SANA - Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share as of Q2 2021.
Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64.1M shares
of 266M outstanding shares and own 24.04% of the company stock.
Largest 10 shareholders include BAILLIE GIFFORD & CO (11.2M shares), CANADA PENSION PLAN INVESTMENT BOARD (10.2M shares), FMR LLC (8.55M shares), Public Sector Pension Investment Board (4.51M shares), Crestline Management, LP (3.21M shares), Alphabet Inc. (2.81M shares), SB Management Ltd (2.63M shares), VANGUARD GROUP INC (2.46M shares), STATE STREET CORP (1.98M shares), and BlackRock Inc. (1.81M shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.